Henderson Group PLC reduced its stake in shares of Aetna Inc. (NYSE:AET) by 6.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 41,826 shares of the company’s stock after selling 3,075 shares during the period. Henderson Group PLC’s holdings in Aetna were worth $5,109,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Renaissance Technologies LLC raised its position in Aetna by 111.5% in the first quarter. Renaissance Technologies LLC now owns 412,190 shares of the company’s stock valued at $46,310,000 after buying an additional 217,300 shares during the last quarter. PGGM Investments raised its position in Aetna by 54.7% in the second quarter. PGGM Investments now owns 794,893 shares of the company’s stock valued at $97,080,000 after buying an additional 280,978 shares during the last quarter. Bridger Management LLC acquired a new position in Aetna during the first quarter valued at approximately $62,926,000. Panagora Asset Management Inc. raised its position in Aetna by 10.2% in the first quarter. Panagora Asset Management Inc. now owns 1,212,479 shares of the company’s stock valued at $136,222,000 after buying an additional 112,572 shares during the last quarter. Finally, Nisa Investment Advisors LLC raised its position in Aetna by 4.1% in the second quarter. Nisa Investment Advisors LLC now owns 145,191 shares of the company’s stock valued at $17,732,000 after buying an additional 5,750 shares during the last quarter. Hedge funds and other institutional investors own 91.94% of the company’s stock.
Shares of Aetna Inc. (NYSE:AET) traded up 2.71% during trading on Tuesday, hitting $111.43. 3,601,754 shares of the stock traded hands. The firm’s 50-day moving average price is $114.61 and its 200-day moving average price is $115.71. The company has a market cap of $39.09 billion, a price-to-earnings ratio of 16.33 and a beta of 0.54. Aetna Inc. has a 52 week low of $92.42 and a 52 week high of $123.57.
Aetna (NYSE:AET) last posted its earnings results on Tuesday, August 2nd. The company reported $2.21 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.12 by $0.09. Aetna had a return on equity of 16.44% and a net margin of 3.89%. The firm earned $15.95 billion during the quarter, compared to analyst estimates of $15.69 billion. During the same period in the previous year, the company earned $2.05 EPS. The company’s revenue for the quarter was up 4.7% on a year-over-year basis. On average, equities research analysts anticipate that Aetna Inc. will post $8.05 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Thursday, October 13th will be issued a dividend of $0.25 per share. The ex-dividend date is Tuesday, October 11th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 0.90%. Aetna’s dividend payout ratio (DPR) is presently 14.73%.
Several research analysts recently commented on AET shares. Credit Suisse Group AG restated a “hold” rating and issued a $120.00 price target on shares of Aetna in a report on Tuesday, August 30th. Leerink Swann reiterated an “outperform” rating on shares of Aetna in a research note on Wednesday, August 24th. Evercore ISI assumed coverage on shares of Aetna in a research note on Thursday, September 22nd. They set a “buy” rating and a $128.00 price objective on the stock. Zacks Investment Research upgraded shares of Aetna from a “hold” rating to a “buy” rating and set a $128.00 price objective on the stock in a research note on Tuesday, October 4th. Finally, Jefferies Group reiterated a “hold” rating on shares of Aetna in a research note on Tuesday, August 23rd. Six analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Aetna has an average rating of “Buy” and a consensus price target of $132.43.
In other news, insider Shawn M. Guertin sold 45,328 shares of the company’s stock in a transaction that occurred on Tuesday, August 23rd. The stock was sold at an average price of $120.21, for a total transaction of $5,448,878.88. Following the completion of the transaction, the insider now directly owns 44,883 shares in the company, valued at $5,395,385.43. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Jeffrey E. Garten sold 7,100 shares of the company’s stock in a transaction that occurred on Wednesday, September 7th. The stock was sold at an average price of $116.51, for a total value of $827,221.00. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.